How I treat leukemia during pregnancy

Chelghoum, 2005, Acute leukemia during pregnancy: a report on 37 patients and a review of the literature., Cancer, 104, 110, 10.1002/cncr.21137 Greenlund, 2001, Acute leukemia during pregnancy: a single institutional experience with 17 cases., Leuk Lymphoma, 41, 571, 10.3109/10428190109060347 Culligan, 2007, The management of acute promyelocytic leukaemia presenting during pregnancy., Clin Leukemia, 1, 183, 10.3816/CLK.2007.n.006 Weisz, 2004, Impact and treatment of cancer during pregnancy., Expert Rev Anticancer Ther, 4, 889, 10.1586/14737140.4.5.889 Brenner, 2012, Haematological cancers in pregnancy., Lancet, 379, 580, 10.1016/S0140-6736(11)61348-2 El-Hemaidi, 2012, Management of haematological malignancy in pregnancy., Best Pract Res Clin Obstet Gynaecol, 26, 149, 10.1016/j.bpobgyn.2011.10.007 Pacifici, 1995, Placental transfer of drugs administered to the mother., Clin Pharmacokinet, 28, 235, 10.2165/00003088-199528030-00005 Cardonick, 2004, Use of chemotherapy during human pregnancy., Lancet Oncol, 5, 283, 10.1016/S1470-2045(04)01466-4 Germann, 2004, Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients., Ann Oncol, 15, 146, 10.1093/annonc/mdh009 Azim, 2010, Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors., Cancer Treat Rev, 36, 101, 10.1016/j.ctrv.2009.11.007 Wagner, 1980, Congenital abnormalities in baby born to cytarabine treated mother., Lancet, 2, 98, 10.1016/S0140-6736(80)92986-4 Shapira, 2008, How I treat acute and chronic leukemia in pregnancy., Blood Rev, 22, 247, 10.1016/j.blre.2008.03.006 Siu, 2002, Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy., Int J Gynecol Cancer, 12, 399, 10.1046/j.1525-1438.2002.01128.x Consoli, 2004, Acute promyelocytic leukemia during pregnancy: report of 3 cases., Int J Hematol, 79, 31, 10.1007/BF02983530 Valappil, 2007, Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature., Hematology, 12, 415, 10.1080/10245330701448594 Avilés, 2006, Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy., Ann Oncol, 17, 286, 10.1093/annonc/mdj053 Gziri, 2013, Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study., Eur J Pediatr, 172, 163, 10.1007/s00431-012-1849-7 Smit, 1999, Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure., J Clin Invest, 104, 1441, 10.1172/JCI7963 Bueno, 2011, Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukaemia with MLL-AF4 rearrangement., Leukemia, 25, 400, 10.1038/leu.2010.284 Williams, 2000, Antineoplastic drugs administered during pregnancy., Semin Oncol, 27, 618 Amant, 2012, Safety of chemotherapy in pregnancy., Clin Adv Hematol Oncol, 10, 258 Matalon, 2005, The effect of 6-mercaptopurine on early human placental explants., Hum Reprod, 20, 1390, 10.1093/humrep/deh721 Cassina, 2012, Genetic susceptibility to teratogens: state of the art., Reprod Toxicol, 34, 186, 10.1016/j.reprotox.2012.05.004 Avilés, 2012, Hematological malignancies and pregnancy: treat or no treat during first trimester., Int J Cancer, 131, 2678, 10.1002/ijc.27560 Abdel-Hady, 2012, Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy., Arch Gynecol Obstet, 286, 283, 10.1007/s00404-012-2287-5 Avilés, 2001, Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero., Clin Lymphoma, 2, 173, 10.3816/CLM.2001.n.023 Nulman, 2001, Neurodevelopment of children exposed in utero to treatment of maternal malignancy., Br J Cancer, 85, 1611, 10.1054/bjoc.2001.2090 Yang, 2009, Treatment of acute promyelocytic leukemia during pregnancy., Pharmacotherapy, 29, 709, 10.1592/phco.29.6.709 Sanz, 2009, Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet., Blood, 113, 1875, 10.1182/blood-2008-04-150250 Reynoso, 1994, Acute leukemia and pregnancy—fatal fetal outcome after exposure to idarubicin during the second trimester., Acta Oncol, 33, 709 Achtari, 2000, Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy., Am J Obstet Gynecol, 183, 511, 10.1067/mob.2000.105964 Claahsen, 1998, Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy—a case report., Am J Perinatol, 15, 295, 10.1055/s-2007-993946 Naujokas, 2013, The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem., Environ Health Perspect, 121, 295, 10.1289/ehp.1205875 Simone, 1995, All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukaemia., Leukemia, 9, 1412 Fenaux, 1999, A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia., Blood, 94, 1192, 10.1182/blood.V94.4.1192 Tallman, 1997, All-trans-retinoic acid in acute promyelocytic leukemia., N Engl J Med, 337, 1021, 10.1056/NEJM199710093371501 Terada, 1997, Foetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukaemia with all-trans retinoic acid and favorable outcome., Leukemia, 11, 454, 10.1038/sj.leu.2400595 Avilés, 1988, Long-term follow-up of children born to mothers with acute leukemia during pregnancy., Med Pediatr Oncol, 16, 3, 10.1002/mpo.2950160102 Hyoun, 2012, Teratogen update: methotrexate., Birth Defects Res A Clin Mol Teratol, 94, 187, 10.1002/bdra.23003 Bawle, 1998, Adult and two children with fetal methotrexate syndrome., Teratology, 57, 51, 10.1002/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9 Feldkamp, 1993, Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy., Teratology, 47, 533, 10.1002/tera.1420470605 Ticku, 2013, Acute lymphoblastic leukemia in pregnancy: a case report with literature review., Ther Adv Hematol, 4, 313, 10.1177/2040620713492933 Pasternak, 2013, Ondansetron in pregnancy and risk of adverse fetal outcomes., N Engl J Med, 368, 814, 10.1056/NEJMoa1211035 Matok, 2009, The safety of metoclopramide use in the first trimester of pregnancy., N Engl J Med, 360, 2528, 10.1056/NEJMoa0807154 Howland, 2009, Categorizing the safety of medications during pregnancy and lactation., J Psychosoc Nurs Ment Health Serv, 47, 17, 10.3928/02793695-20090401-06 Sanofi. Summary of product characteristics: Targocid, Teicoplanin. www.sanofi-aventis.co.uk/products/Targocid_SPC.pdf. Accessed November 20, 2013 electronic Medicines Compendium. SPC: Vancomycin 1g powder for solution for infusion. www.medicines.org.uk/emc/medicine/20835/SPC. Accessed November 10, 2008 Nahum, 2006, Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks., Obstet Gynecol, 107, 1120, 10.1097/01.AOG.0000216197.26783.b5 Koren, 1998, Drugs in pregnancy., N Engl J Med, 338, 1128, 10.1056/NEJM199804163381607 Einarson, 2001, Effects of antibacterials on the unborn child: what is known and how should this influence prescribing., Paediatr Drugs, 3, 803, 10.2165/00128072-200103110-00003 Cottle, 2002, Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor., Semin Hematol, 39, 134, 10.1053/shem.2002.31914 Moudgal, 2003, Antifungal drugs in pregnancy: a review., Expert Opin Drug Saf, 2, 475, 10.1517/14740338.2.5.475 Baran, 2008, Review of antifungal therapy and the severity index for assessing onychomycosis: part I., J Dermatolog Treat, 19, 72, 10.1080/09546630701243418 Briggs, 2011, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 9th ed Sobel, 2000, Use of antifungal drugs in pregnancy: a focus on safety., Drug Saf, 23, 77, 10.2165/00002018-200023010-00005 De Santis, 2009, First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy., Drug Saf, 32, 239, 10.2165/00002018-200932030-00006 Shoai Tehrani, 2013, Case report of exposure to voriconazole in the second and third trimesters of pregnancy., Antimicrob Agents Chemother, 57, 1094, 10.1128/AAC.00899-12 Mueller, 2006, A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan., J Antimicrob Chemother, 58, 811, 10.1093/jac/dkl342 Schaefer, 2007, Drugs During Pregnancy and Lactation, 2nd ed Groll, 2001, Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections., Expert Opin Investig Drugs, 10, 1545, 10.1517/13543784.10.8.1545 Czeizel, 2003, A population-based case-control teratological study of oral nystatin treatment during pregnancy., Scand J Infect Dis, 35, 830, 10.1080/00365540310017069 Lichtman, 2001, Acute myelogenous leukemia. Williams Hematology., 6th ed Apperley, 2009, CML in pregnancy and childhood., Best Pract Res Clin Haematol, 22, 455, 10.1016/j.beha.2009.09.008 Milojkovic, 2008, State-of-the-art in the treatment of chronic myeloid leukaemia., Curr Opin Oncol, 20, 112, 10.1097/CCO.0b013e3282f1fe8a Nurmio, 2008, Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis., Reprod Toxicol, 25, 442, 10.1016/j.reprotox.2008.03.004 Apperley, 2008, The haematological malignancies., Cancer and Reproductive Health, 10.1017/CBO9781107786110.020 Strobl, 1999, Management of chronic myeloid leukemia during pregnancy with leukapheresis., J Clin Apher, 14, 42, 10.1002/(SICI)1098-1101(1999)14:1<42::AID-JCA8>3.0.CO;2-2 Yazdani Brojeni, 2012, A systematic review of the fetal safety of interferon alpha., Reprod Toxicol, 33, 265, 10.1016/j.reprotox.2011.11.003 Harrison, 2005, Pregnancy and its management in the Philadelphia negative myeloproliferative diseases., Br J Haematol, 129, 293, 10.1111/j.1365-2141.2005.05400.x Pye, 2008, The effects of imatinib on pregnancy outcome., Blood, 111, 5505, 10.1182/blood-2007-10-114900 Ault, 2006, Pregnancy among patients with chronic myeloid leukemia treated with imatinib., J Clin Oncol, 24, 1204, 10.1200/JCO.2005.04.6557 Cole, 2009, Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature., Clin Lymphoma Myeloma, 9, 324, 10.3816/CLM.2009.n.064 AlKindi, 2005, Imatinib in pregnancy., Eur J Haematol, 74, 535, 10.1111/j.1600-0609.2005.00420.x Cortes, 2008, Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib [abstract]., Blood, 10.1182/blood.V112.11.3230.3230 Conchon, 2009, Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study., J Hematol Oncol, 2, 42, 10.1186/1756-8722-2-42 Berveiller, 2012, A dramatic fetal outcome following transplacental transfer of dasatinib., Anticancer Drugs, 23, 754, 10.1097/CAD.0b013e328352a8fe Kroll, 2010, Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib., Leuk Lymphoma, 51, 1751, 10.3109/10428194.2010.497982 Conchon Bayraktar, Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester., BMJ Case Rep, 10.1136/bcr.05.2010.2975 Garderet, 2007, Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib., Haematologica, 92, e9, 10.3324/haematol.10935 He, 2008, Lacteal secretion, fetal and maternal tissue distribution of dasatinib in rats., Drug Metab Dispos, 36, 2564, 10.1124/dmd.108.022764 Thauvin-Robinet, 2001, Exposure to hydroxyurea during pregnancy: a case series., Leukemia, 15, 1309, 10.1038/sj.leu.2402168 Zhou, 2013, Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor., Leuk Res, 37, 1216, 10.1016/j.leukres.2013.07.020 Ross, 2013, Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study., Blood, 122, 515, 10.1182/blood-2013-02-483750 Mahon, 2010, Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial., Lancet Oncol, 11, 1029, 10.1016/S1470-2045(10)70233-3 Kuwabara, 2010, Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response., Blood, 116, 1014, 10.1182/blood-2010-04-280206 Ali, 2004, Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis., Ann Hematol, 83, 61, 10.1007/s00277-003-0723-0 Ali, 2009, Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil., Leuk Res, 33, 567, 10.1016/j.leukres.2008.05.019 Chakravarty, 2011, Pregnancy outcomes after maternal exposure to rituximab., Blood, 117, 1499, 10.1182/blood-2010-07-295444 Adeniji Daver, 2013, Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options., Clin Lymphoma Myeloma Leuk, 13, 86, 10.1016/j.clml.2012.06.009 Kumar, 2000, Transfer of interferon alfa into human breast milk., J Hum Lact, 16, 226, 10.1177/089033440001600308 Ali, 2009, Imatinib use during pregnancy and breast feeding: a case report and review of the literature., Arch Gynecol Obstet, 280, 169, 10.1007/s00404-008-0861-7 Kronenberger, 2009, Imatinib in breast milk., Ann Hematol, 88, 1265, 10.1007/s00277-009-0754-2 Cardonick, 2010, Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry., Am J Clin Oncol, 33, 221, 10.1097/COC.0b013e3181a44ca9 Amant, 2012, Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study., Lancet Oncol, 13, 256, 10.1016/S1470-2045(11)70363-1